Using ‘trip killers’ to cut short bad drug trips is potentially dangerous.
As interest in psychedelics has grown, so has interest in ways to end a bad trip.
Recent research reveals that people are giving potentially dangerous advice on social media on how to stop a trip that is less than pleasurable.
Read more
We live in a bustling, crowded world, yet loneliness appears to be on the rise.
Why are so many of us feeling isolated and what can we do about it?
Read more
There is an ever-growing list of the benefits of natural prescriptions – now researchers say nature could offer a cure for loneliness too.
Read more
Here’s an article from TIME magazine on talking about grief.
Read more
Psychedelics such as psilocybin and MDMA may be a promising treatment avenue for Prolonged Grief Disorder (PGD).
Randomized clinical trials demonstrated the efficacy of psilocybin in reducing symptom severity in depression and MDMA in reducing PTSD symptomatology.
Furthermore, psychedelics often produce subjective effects (such as transcendence, mystical experiences, and a sense of oneness) that may be uniquely relevant to the existential distress experienced in PGD.
Read more
In a new study, researchers found that psychological flexibility, several facets of mindfulness, and values-congruent living significantly improved following psilocybin and were maintained through week 16.
Additionally, improvements in psychological flexibility and experiential acceptance were strongly associated with reductions in depression severity following psilocybin.
Keep reading for the full article at Nature.com
Read more
Are psychedelics an antidote to pessimism?
Research indicates that psychedelic therapy can improve mental health outcomes by addressing the pessimism bias.
Read more
In the 1960s, psychedelic research was driven underground. Now it’s re-emerging – with lessons for the study of psychosis.
Read more